Urticaria
📧 Sign up to get email alerts when something new happens for Urticaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-03-25FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) from Kenvue Brands LLC, indicating a label/indicatio…
-
FDA approval · 2025-03-13FDA Approved: ALLERGY RELIEF — Supplemental Application (Prodose, Inc)
FDA approved a supplemental application for ALLERGY RELIEF (cetirizine hydrochloride) by Prodose, Inc, authorizing a change under theANDA.
-
FDA approval · 2024-11-26FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) to expand the label for the treatment of urticaria (hive…
-
FDA approval · 2024-11-15FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) by Kenvue Brands LLC. The approval adds or expands the…
-
FDA approval · 2024-11-13FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Children's Zyrtec (cetirizine hydrochloride) by Kenvue Brands LLC. The approval pertains to a mo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-03FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Indoco Remedies Limited)
FDA approved Indoco Remedies Limited's original application for cetirizine hydrochloride, granting approval for a generic antihistamine prod…
-
FDA approval · 2024-08-15FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) filed by Kenvue Brands LLC.
-
FDA approval · 2024-05-22FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC., indicating an approved post-approval c…
-
FDA approval · 2024-03-28FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) by Kenvue Brands LLC. The approval covers cetirizine…
-
FDA approval · 2024-03-20FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved a generic diphenhydramine hydrochloride product through an Original Application (ANDA 218448) by Sagent Pharmaceuticals.
-
FDA approval · 2024-01-04FDA Approved: ALLERGY RELIEF — Supplemental Application (WALMART INC. (see also Equate))
FDA approved a supplemental application for ALLERGY RELIEF containing fexofenadine HCl, manufactured by Walmart Inc.
-
FDA approval · 2023-12-01FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application to expand ZYRTEC HIVES labeling for the treatment of urticaria (hives) with cetirizine hydrochloride…
-
FDA approval · 2023-10-13FDA Approved: LORATADINE — Supplemental Application (Wal-Mart Stores, Inc)
The FDA approved a supplemental application for loratadine submitted by Wal-Mart Stores, Inc. for an existing loratadine product.
-
FDA approval · 2023-08-17FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for hydroxyzine hydrochloride from Rising Pharma Holdings, Inc., confirming a generic antihistamine pro…
-
FDA approval · 2023-08-01FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) by Chattem, Inc. The product is indicated fo…
-
FDA approval · 2023-07-28FDA Approved: LORATADINE — Original Application (Camber Consumer Care Inc)
The FDA approved Camber Consumer Care Inc's loratadine product via an Original Application (ANDA211718), providing a generic loratadine opti…
-
EMA approval · 2023-06-01EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
The EMA has authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria indications in the European Union.
-
FDA approval · 2023-05-25FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin RediTabs (loratadine) to introduce a new dosage form for Bayer HealthCare LLC.
-
FDA approval · 2023-05-08FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) by Kenvue Brands LLC, updating the label to address trea…
-
FDA approval · 2023-04-19FDA Approved: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION — Supplemental Application (APOZEAL PHARMACEUTICALS INC)
FDA approved a supplemental application for cetirizine hydrochloride oral solution by Apozeal Pharmaceuticals, updating the approved labelin…
-
FDA approval · 2023-04-13FDA Approved: ALLERGY RELIEF — Supplemental Application (WALGREENS)
FDA approves Walgreens' supplemental application for an allergy-relief product containing cetirizine hydrochloride (Allergy Relief).
-
FDA approval · 2023-03-24FDA Approved: LORATADINE — Original Application (Aurohealth LLC)
The FDA approved Aurohealth LLC's original application for loratadine, a generic antihistamine. It covers indications for allergic rhinitis …
-
FDA approval · 2022-12-27FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a new chewable grape and bubblegum formulation of Claritin (loratadine) from Bayer HealthCare…
-
FDA approval · 2022-12-27FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy containing fexofenadine hydrochloride, submitted by Chattem, Inc., to…
-
FDA approval · 2022-12-20FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) to support labeling for pediatric use, e…